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Abstract
Many catabolic stimuli, including interleukin-1 (IL-1) in combination with oncostatin M (OSM),
promote cartilage breakdown via the induction of collagen-degrading collagenases such as
matrix metalloproteinase 1 (MMP1) and MMP13 in human articular chondrocytes. Indeed,
joint diseases with an inflammatory component are characterised by excessive extracellular
matrix (ECM) catabolism. Importantly, protein kinase C (PKC) signalling has a primary role in
cytokine-induced MMP1/13 expression, and is known to regulate cellular functions associ-
ated with pathologies involving ECM remodelling. At present, substrates downstream of PKC
remain undefined. Herein, we show that both IL-1- and OSM-induced phosphorylation of pro-
tein kinase D (PKD) in human chondrocytes is strongly associated with signalling via the
atypical PKCι isoform. Consequently, inhibiting PKD activation with a pan-PKD inhibitor sig-
nificantly reduced the expression of MMP1/13. Specific gene silencing of the PKD isoforms
revealed that only PKD3 (PRKD3) depletion mirrored the observed MMP repression, indica-
tive of the pharmacological inhibitor specifically affecting only this isoform. PRKD3 silencing
was also shown to reduce serine phosphorylation of signal transducer and activator of tran-
scription 3 (STAT3) as well as phosphorylation of all three mitogen-activated protein kinase
groups. This altered signalling following PRKD3 silencing led to a significant reduction in the
expression of the activator protein-1 (AP-1) genes FOS and JUN, critical for the induction of
many MMPs including MMP1/13. Furthermore, the AP-1 factor activating transcription factor
3 (ATF3) was also reduced concomitant with the observed reduction in MMP13 expression.
Taken together, we highlight an important role for PKD3 in the pro-inflammatory signalling
that promotes cartilage destruction.
Introduction
The progression of joint diseases such as rheumatoid arthritis (RA) and osteoarthritis (OA)
is associated with inflammation, whereby inflammatory mediators released by infiltrating
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immune cells as well as resident joint cells induce altered gene expression that promotes extra-
cellular matrix (ECM) degradation [1]. Cytokines such as interleukin (IL-)1 and tumour ne-
crosis factor α (TNFα) are key mediators in the inflammatory responses in destructive joint
disease [2,3], and we have previously demonstrated enhanced cartilage ECM catabolism by
these mediators when combined with IL-6-family cytokines such as oncostatin M (OSM) in
vitro and in vivo [4–8]. This co-operative exacerbation in catabolic potential is likely to occur
in many inflammatory milieu, such as the arthritides, to promote cartilage ECM catabolism.
Normal articular cartilage is maintained by a single resident cell type, the chondrocyte,
which preserve homeostasis by regulating the expression of ECM components and catabolic
factors such as the matrix metalloproteinases (MMPs). Collectively, the MMPs can degrade all
ECM macromolecules, and during inflammatory joint diseases stimulated chondrocytes se-
crete elevated levels of MMPs which, once activated, mediate proteolysis of tendon, bone and
cartilage [9,10]. MMP-1 and MMP-13 are the collagenolytic MMPs most strongly associated
with cartilage collagenolysis, a key proteolytic event in joint diseases since it is essentially irre-
versible [11]. Indeed, MMP-13 is the most potent collagenase with respect to type II collagen
[12], the major structural collagen in articular cartilage. Potent pro-inflammatory stimuli such
as IL-1+OSM activate a complex array of signal transduction pathways, shown to be common
to a wide variety of pro-inflammatory stimuli [13], which together markedly enhance the
induction of MMP1/13 in human chondrocytes [7,13–15]. The cFos/cJun activator protein-1
(AP-1) transcription factor complex is critical for MMP gene expression (see [16] and refer-
ences therein), although we recently reported a role for the AP-1-binding factor activating
transcription factor 3 (ATF3) in selectively mediating MMP13 expression which was neverthe-
less AP-1-dependent [13]. Furthermore, we have also previously demonstrated the importance
of signal transducer and activator of transcription (STAT)3, phosphatidylinositol-3’ kinase
(PI3K/Akt) and protein kinase C (PKC) signalling pathways [17–19]. The atypical PKC iso-
form PKCι has been shown to modulate MMP1/13 induction following IL-1+OSM stimulation
[19], but the identity of the downstream signalling components it affects remains unknown, as
do potential points of cross-talk.
Protein kinase D (PKD) comprises a family of serine/threonine protein kinases that
belong to the Ca2+/calmodulin-dependent kinase superfamily. Three isoforms exist in
humans: PKD1, PKD2 and PKD3 (reviewed in [20]). Diverse cellular functions, including
cell survival/proliferation and apoptosis, plasma membrane-directed transport, metastasis
and inflammation have been reported [20–24] for PKD isoforms. With respect to cartilage
remodelling, PKD is reported to regulate both the expression and activity of several MMPs.
Studies have shown that PKD1 down-regulates the expression and activity of multiple
MMPs in breast cancer cells lines, particularly the gelatinase MMP-9 [22]. Conversely, gene
silencing of PKD2 and PKD3 leads to a decrease in the activity of MMP-9 in prostate can-
cer, suggesting MMP gene regulation by distinct PKD family members is cell-type specific.
PKD3 has been reported to regulate nuclear localization and activity of histone deacetylases
5 and 7 (HDAC5/7) [25]. OA cartilage exhibits elevated HDAC7 levels, whilst HDAC7
depletion in SW1353 human chondrosarcoma cells strongly suppressed IL-1-dependent
induction of MMP13 [26]. PKD3 can be activated independently of PKC via phosphoryla-
tion of tyrosine residues within the pleckstrin homology domain following oxidative stress,
which is a feature of OA [27]. Moreover, PKD isoforms have also been shown to be a down-
stream target of G-protein-coupled receptors, via increases in phospholipase C activity and
auto-phosphorylation [28]. Such receptors play roles in innate and adaptive immunity, and
have been implicated in the pathology associated with arthritis [29–31].
PKD3 is ubiquitously expressed in adult human tissues [32] and has been shown to be
expressed during skeletogenesis in mice, notably in the cartilage primordia of bones [33],
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which are areas of active ECM turnover (via MMP-13) as cartilage is remodelled prior to min-
eralization. Interestingly, phenotypic analysis of a mutant mouse strain harbouring a gene-trap
deletion of the PKD3 gene (prkd3) revealed a mild skeletal abnormality including decreased
mean trabecular bone volume and thickness [34], suggestive of reduced remodelling in carti-
lage primordia. In this context, downstream PKD3 signalling may also be involved in cyto-
kine-induced MMP13 expression in human chondrocytes. Herein, we show that PKD3 is
indeed involved in pro-inflammatory signalling via modulating the expression of the AP-1
genes FOS and JUN, and enhancing MMP expression. PKD3 activity also stimulates the induc-
tion of ATF3 which is specifically involved in cytokine-induced MMP13 expression in human
chondrocytes.
Materials and methods
Materials
All chemicals were obtained from Sigma Chemical Co (Poole, UK) unless otherwise stated and
of the highest purity available. All cytokines were recombinant human. IL-1α was a generous
gift from Dr Keith Ray (GlaxoSmithKline, Stevenage, UK). OSM was prepared in-house using
expression vectors kindly provided by Prof. J. Heath (University of Birmingham, UK) and
methods described [35]. Go¨6983 was from Merck Chemicals (Nottingham, UK). PKD inhibi-
tor kb NB 142–70 was from Tocris Bioscience (Bristol, UK). The STAT3 inhibitor S31-201 was
from Selleckchem (TX, USA). Kinase inhibitors and small interfering (siRNA) reagents were
screened for toxicity using the Toxilight assay of adenylate kinase release (Lonza, Wokingham,
UK), and always used at concentrations that did not affect cell viability over the assay period.
Chondrocytes
Human chondrocytes were obtained by the enzymatic digestion of macroscopically normal
articular cartilage from OA patients undergoing joint replacement surgery as described [36].
All subjects gave informed consent and the study was approved by the Newcastle and North
Tyneside Joint Ethics Committee (REC 14/NE/1212). Chondrocytes were maintained in Dul-
becco’s modified Eagle’s medium (DMEM) supplemented with 10% foetal bovine serum
(FBS), 100 IU penicillin, 100 μg/ml streptomycin, 40 U/ml nystatin.
Cell fractionation and immunoblotting
Chondrocyte lysates were prepared as described previously (18) and stimulated with IL-1 (0.2
ng/ml) ± OSM (10 ng/ml) for up to 60 min. In some experiments, chondrocytes were subjected
to subcellular fractionation using NE-PER Nuclear and Cytoplasmic Protein Extraction Kit or
Subcellular Protein Fractionation Kit (both from ThermoFisher Scientific, Loughborough, UK).
GAPDH was used as a loading control for whole cell lysates whilst MEK2 and lamin A/C were
used for cytoplasmic and nuclear extracts, respectively. Lysates or fractions were resolved by
SDS-PAGE, transferred to PVDF membranes and subsequently probed using the following anti-
bodies: PKCι (#2998), PKCz (#9372), PKD
S916 (#2051), PKD
S744/748 (#2054: recognises
PKD
S731/735 in PKD3), PKD3 (#5655), ERK1/2
T202/Y204 (#9101), JNK (#9252), JNK
T183/Y185
(#9251), p38
T180/Y182 (#9211), Akt
S473 (#4060), cFos (#4384), STAT1
Y701 (#9171), STAT1
S727
(#9177), STAT3
Y705 (#9131), STAT3
S727 (#9134) and lamin A/C (#2032) were from Cell Signal-
ing Technology (Danvers, MA); cJun (sc1694) and ATF3 (sc188) were from Santa Cruz Biotech-
nology (Santa Cruz, CA); glyceraldehyde 3’-phosphate dehydrogenase (GAPDH; MAB374) was
from Millipore (MA, USA); PKD1 (L905) was from Bio-world (Dublin, USA); MEK2 (#04–377)
and PKD2 (#1969–1) were from Epitomics (Insight Biotech, Wembley, UK). The specificity of
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all antibodies was confirmed using chondrocyte lysates (see full-length blots in S1 Fig), whilst
blots were cropped for clarity of comparison.
Gene silencing
PRKCZ and PRKCI siRNAs were Dharmacon ON-TARGETplus™ (ThermoFisher Scientific),
comprising 4 specific siRNA complexes [16], whilst validated MISSION™ siRNA reagents
(Sigma) were used to silence: PRKD2, 5’-CGAUACAUCACGCAUGAGA-3’; PRKD3, 5’-CAU
AAACGCUGUGCAUCAA-3’; JNK1, 5’-GUUCUUAUGAAAUGUGUUATT-3’; JNK2,5’-CUG
UAACUGUUGAGAUGUATT-3’. Primary human chondrocytes were prepared and cultured as
above, and transfected as described previously (18). After transfection, cells were serum-starved
for 24 h prior to stimulation as indicated. Depletion of gene-specific mRNA levels was calcu-
lated by comparison of expression levels with cells transfected with 100 nM siCONTROL
(siCon: non-targeting siRNA #2, Cat. 001210–02; Dharmacon).
GIPZ lentiviral vector containing non-targeting control shRNA (shCon) or PRKD1 shRNA
(shPRKD1: V2LHS-170466) were purchased from OpenBiosystems (Thermo Fisher Scientific).
Packaging and envelope plasmids pCMV-dR8.91 and pMD2.G were a kind gift from Prof.
Nick Reynolds (Newcastle University). The HEK293T producer cell line (SBI, California,
USA), maintained in DMEM plus 10% FBS, was employed for packaging. On the day of trans-
fection, medium was changed to DMEM containing 10% heat-inactivated FBS. Packaging,
envelope and shRNA plasmids were co-transfected using JetPEI transfection reagent (Poly-
plus, Illkirch, France), according to the manufacturer’s instructions. Supernatant was har-
vested 72 h post-transfection and filtered (0.45 μm). Viral particles were then concentrated
50-fold using a Lenti-X concentrator (Takara Bio Europe/ Clontech, Saint-Germain-en-Laye,
France), and viral titre calculated using the Lenti-X qRT-PCR Titration Kit (Takara). Multi-
plicity of infection (MOI) was then calculated via serial dilution. Primary chondrocytes were
prepared and cultured as above, and exposed to lentiviral infection at a MOI of 30 for 72 h.
Transduction was assessed using confocal microscopy for green fluorescent protein (GFP).
After transduction, cells were serum-starved for 24 h then stimulated as indicated.
Real-time PCR of relative mRNA levels
Primary human chondrocytes were stimulated with IL-1 (0.05 ng/ml) ± OSM (10 ng/ml) for 1
h to measure FOS, JUN and ATF3, or 24 h for MMP mRNAs. RNA was stabilised in cell lysates
in a 96-well format, cDNA synthesised and real-time PCR assays conducted using conditions
described previously [18]. Primer and probe sequences are as previously detailed [13,19], or
MMP8: For, 5’- CACTCCCTCAAGATGACATCGA-3’ and Rev, 5’-ACGGAGTGTGGTGA
TAGCATCA-3’, Probe, 5’-CAAGCAACCCTATCCAA CCTACTGGACCAA-3’; MMP14: For,
5’-AGGCCGACATCATGATCTTCTTT-3’ and Rev, 5’-AAGTGGGTGTCTCCTCCAATGTT
-3’, Probe, 5’-CCATGGCGACAGCACGC CCTT-3’. Some Taqman assays used Universal
Probe Library probes (Roche Applied Sciences) as directed: PRKD1: For, 5’- TGTATTACCC
TCTTTCAGAATGACA-3’and Rev, 5’-CCAGAGACAAAATTTCAGATAAAGG-3’, Probe: 38;
PRKD2: For, 5’-AGATGCTC TTCGGCCTAGTG-3’ and Rev, 5’-AGCGCTTGTGGTAGTT
CAGC-3’, Probe: 46; PRKD3: For, 5’-TGATTTAAAGCCAGAAAATGTGC-3’ and Rev, 5’-
CGTGCAAATCC AAAGTCACA-3’, Probe: 21.
Statistical analyses
Statistical differences between sample groups were assessed using one-way analysis of variance
(ANOVA) with a post-hoc Bonferroni’s multiple comparison test or Student’s 2-tailed unpaired
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t-test (1 sample t-test for immunoblot quantification), where p<0.001, p<0.01, p<0.05.
For clarity, only selected comparisons are presented in some Figures.
Results
Inhibition of PKD phosphorylation curtails IL-1+OSM induction of MMP1
and MMP13 in human articular chondrocytes
We previously demonstrated roles for PKCι and PKCz in IL-1+OSM-mediated expression of
the key collagenases MMP1 and MMP13 in human chondrocytes [19]. Moreover, we have also
shown both IL-1 and OSM induce PKD phosphorylation such that we sought to confirm that
PKD was indeed a downstream substrate of PKC signalling. Cytokine-induced PKD phos-
phorylation was assessed in the presence of the Gӧ6983 (20 μM), a PKC inhibitor that does not
inhibit PKD, which completely abolished both IL-1- and OSM-stimulated PKD phosphoryla-
tion (Figs 1A and S2). Assessment of the effect of gene silencing of PRKCI and PRKCZ (coding
for PKCι and PKCz, respectively; S3A Fig) indicated that, of the atypical PKC isoforms, only
PKCι played a role in this phosphorylation (Fig 1B and 1C).
Since combined PKC/PKD inhibition (using Gӧ6976) suppressed MMP expression and
reduced cytokine-induced collagen release from cartilage [16], we confirmed that a specific
PKD inhibitor (NB142-70; PKDi) also significantly reduced IL-1+OSM-induced expression of
MMP1 and MMP13 expression (Fig 1D). Together, these findings implicate a role for PKD in
cytokine-induced MMP expression in human chondrocytes.
PKD3 depletion correlates with reduced MMP1 and MMP13 expression in
human chondrocytes
To determine which of the three individual PKD isoforms accounted for the PKDi-mediated
reduction in MMP expression, selective ‘knockdown’ of the PKD isoforms (S3B Fig) indicated
that only PRKD3 silencing led to a significant decrease in the expression of both MMP1 and
MMP13 (Fig 2). Expression of these MMPs was markedly enhanced with PRKD1 silencing
but unaltered following PRKD2 depletion (S4A and S4B Figs, respectively). Since these data
strongly implicated PKD3 as the only ‘pro-inflammatory’ moiety of PKD signalling for cyto-
kine-induced MMP expression, specificity assessment of PRKD3 silencing for the other col-
lagenolytic MMP species indicated that MMP8, but not MMP14, was also significantly
suppressed (S5 Fig).
PKD3 depletion alters STAT signalling in IL-1+OSM-stimulated human
chondrocytes
Analyses of the signalling pathways activated in human chondrocytes following PRKD3 silenc-
ing with IL-1+OSM stimulation revealed reductions in phosphorylation of all three MAPK
groups but no apparent effect on the phosphorylation of Akt
S473 (Fig 3A and 3B). As dual phos-
phorylation of STATs occurs for full activity [37,38], we also observed reductions in Ser727 phos-
phorylation of STAT1 and STAT3 (Fig 3A and 3B), important for transcriptional activity [37],
whilst a more detailed analysis using subcellular fractionation indicated that although cyto-
plasmic (and indeed total) levels of Tyr705 phosphorylation of STAT3 appeared to be relatively
unaffected, reduced nuclear levels were observed (Fig 4A) following PRKD3 depletion. In con-
trast, total and nuclear STAT1
Y701 was unaffected by PRKD3 silencing (Fig 4A).
To further confirm a role for STAT3 in IL-1+OSM-mediated MMP expression [17,19] the
STAT3 inhibitor S31-201 significantly reduced both MMP1 and MMP13 expression in human
chondrocytes (Fig 4B). Since PRKD3 silencing curtailed IL-1+OSM-mediated JNK activation,
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and in light of the previously reported PKD-dependent activation of JNK [39] and our previ-
ous report indicating no dependency for ERK [19], we determined whether the observed
Fig 1. Effect of PKD inhibition on collagenase expression in human chondrocytes. Primary human articular
chondrocytes were stimulated with IL-1 (0.2 ng/ml) alone, OSM (10 ng/ml) alone or IL-1+OSM as detailed in the
Methods for 20 min (A-C). Cells were either (A) pre-treated with Gӧ6983 (20 μM; PKCi) for 1 h or (B and C)
transfected with siRNA for non-targeting siCon (white bars), PRKCZ (grey bars) or PRKCI (black bars) (all 100 nM)
for 48 h prior to stimulation. Cell lysates were prepared as described in Methods and subjected to SDS-PAGE and
immunoblotting (using the antibodies indicated). Relative densitometry of some blots was performed, scans combined
and plotted graphically (C), where ††, p0.01 versus siCon-treated IL-1+OSM. (D) Human chondrocytes were pre-
treated with NB142-70 (5 μM; PKDi), or a DMSO vehicle control for 1 h prior to stimulation with IL-1 (0.05 ng/ml)
+ OSM (10 ng/ml) for 24 h. Real-time RT-PCR was performed on isolated RNA to determine relative levels of MMP1
(black bars) and MMP13 (hatched bars), normalised to 18S rRNA housekeeping gene and presented as a percentage of
the IL-1+OSM induction (n = 6; mean ± S.E.), where , p0.001 versus the relevant DMSO-treated vehicle control.
Data are representative of at least 3 separate chondrocyte populations.
https://doi.org/10.1371/journal.pone.0195864.g001
Fig 2. Effect of PKD isoform silencing on MMP1 and MMP13 expression in human chondrocytes. Following
transfection with siRNA, either non-targeting siCon (white bars) or one specific for PRKD3 (black bars) (both 100
nM), primary human articular chondrocytes were stimulated with IL-1 (0.05 ng/ml) + OSM (10 ng/ml) for 24 h. Cells
were lysed and real-time RT-PCR performed for MMP1 (upper panel) and MMP13 (lower panel), 72 h after the start of
transfection as described in the Materials and Methods. Data (mean ± S.E.) are representative of at least three separate
chondrocyte populations (each assayed in hextuplicate), presented as relative expression levels normalised to 18S rRNA
housekeeping gene, where , p0.01 versus siCon transfection.
https://doi.org/10.1371/journal.pone.0195864.g002
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effects on STAT phosphorylation could be mediated by JNK moieties. Gene silencing of JNK1
and JNK2 revealed that JNK2 appeared to have a role in the Ser727 phosphorylation of both
STAT1 and STAT3 following IL-1+OSM stimulation (Fig 4C and 4D).
Fig 3. Effect of PRKD3 silencing on STAT and MAPK phosphorylation in human chondrocytes. (A) Following
transfection with siRNA specific to PRKD3 or non-targeting siCon (100 nM), primary human articular chondrocytes were
stimulated with IL-1+OSM as detailed in the Methods for the indicated times. Whole cell lysates were prepared and
subjected to SDS-PAGE and immunoblotting using the antibodies indicated. (B) Scans from multiple blots with siCon
(white bars) or siPRKD3 (black bars) were combined and the relative densitometry values presented for the individual
antibodies used, where , p0.01 vs the relevant siCon time point. The data are representative of at least three separate
chondrocyte populations.
https://doi.org/10.1371/journal.pone.0195864.g003
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PKD3 indirectly regulates AP-1 factors in IL-1+OSM-mediated MMP13
expression
Previous data have shown a role for STAT3 in the induction of the AP-1 factor cFos [17], and
we show here that the effect of PRKD3 silencing on STAT3 phosphorylation is concomitant
with a reduction in the expression of both FOS and JUN (Fig 5A) as well as cFos protein and
phosphorylated cJun (Fig 5B and 5C). We have recently reported the involvement of ATF3 in
cytokine-induced MMP13 expression [13], and assessment of ATF3 expression following
PRKD3 silencing confirmed that it was indeed significantly reduced (Fig 6A). This was further
reflected in markedly reduced nuclear ATF3 protein in cytokine-stimulated human chondro-
cytes following PRKD3 gene silencing (Fig 6B and 6C).
Discussion
The signal transduction associated with potent pro-inflammatory stimuli is complex although it
is emerging that many of the activated pathways are common to a multitude of inflammatory
mediators [13]. The interactions and cross-talk serve to markedly enhance MMP induction in
human chondrocytes which ultimately drive ECM cataoblism [6,7,13,14,18,19]. We have used
the catabolic stimulus of IL-1+OSM as a model inflammatory stimulus to investigate the signal-
ling that underpins the expression of collagenolytic MMPs, in particular MMP13 due to its high
capacity to degrade the major structural component of cartilage, type II collagen [12]. Our own
data and those of others [13,17,40] have shown a strong dependence on AP-1 complexes of
cFos/cJun in order for MMP gene expression to occur, and this has been linked to AP-1 consen-
sus motifs in the proximal promoters of both MMP1 and MMP13 (see [16]). Phosphorylation of
PKC isoforms in human chondrocytes occurs following stimulation with IL-1 or OSM, whilst
their silencing has been shown to reduce both MMP1 and MMP13 expression as well as the
induction of FOS [19]. These stimuli also promote phosphorylation of the downstream PKC
substrate, PKD [19]. Herein we extend these observations through the identification of PKCι as
the atypical PKC isoform that mediates downstream PKD phosphorylation. Moreover, pharma-
cological inhibition of PKD species significantly reduced IL-1+OSM-induced MMP1 and
MMP13 expression. However, the PKD inhibitor kb NB142-70 does not discriminate between
PKD isoforms, and indeed many early studies on PKD reported findings relating to PKD as a
single ‘entity’ rather than considering the three individual protein kinase isoforms. In this con-
text, only silencing of PKD3 (PRKD3) mimicked the inhibition of PKDi on MMP1/13 expres-
sion thus highlighting its role in pro-inflammatory signalling in chondrocytes. Moreover, these
data also indicate that stimulation of two specific cytokine receptor pathways (IL-1 and OSM,
respectively) converges on PKD3 activation via PKCι (Fig 7).
Earlier findings indicated that STAT3 is a potent mediator of cytokine-induced MMP expres-
sion in chondrocytes [17,19]. Evidence is provided here too indicate that PRKD3 knockdown also
Fig 4. The role of STATs in PKD3-mediated MMP expression in human chondrocytes. (A) Following transfection
with siRNA specific to PRKD3 or non-targeting siCon (100 nM), primary human articular chondrocytes were
stimulated with IL-1+OSM as detailed in the Methods for the indicated times. Subcellular fractions were prepared and
subjected to SDS-PAGE and immunoblotting using the antibodies indicated. (B) Chondrocytes were pre-treated for 1
h with S31-201 (STAT3i; black bars) or DMSO vehicle control (white bars), and then stimulated with IL-1+OSM for 24
h. Lysates were subjected to real-time RT-PCR (n = 6; mean ± S.E.) for MMP1 and MMP13 as described in Methods.
Data are presented as relative expression levels normalised to 18S rRNA housekeeping gene, where , p0.001, ,
p0.05 vs the relevant DMSO treatment. (C) Chondrocytes were transfected with siCon (white bars), siJNK1 (grey
bars) or siJNK2 (black bars) (all 100 nM) for 48 h prior to stimulation with IL-1+OSM for the indicated durations. Cell
lysates were immunoblotted with the antibodies indicated. Scans from multiple blots were combined and the relative
density values presented for the individual antibodies used (D), where , p0.01 vs the relevant siCon time point. All
data are representative of at least three separate chondrocyte populations.
https://doi.org/10.1371/journal.pone.0195864.g004
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modulates the activation of STATs 1 and 3 via reducing Ser727 phosphorylation, a requirement
for maximal transcriptional activation of target genes [37]. Notably, STAT1/3 tyrosine phosphor-
ylation was unaffected and, since nuclear import of STAT3 is independent of Tyr705 phosphoryla-
tion [38], the reduced nuclear STAT3 was presumably due to a PKD3-dependent alteration in the
importin-α/importin-β1-Ran pathway [38]. Furthermore, the catalytic activity of PKD3 has been
shown to regulate its own nuclear import through auto-phosphorylation and/or interaction with
other proteins [41], such that PRKD3 depletion prior to stimulation could markedly restrict sub-
sequent nuclear trafficking to limit STAT3-dependent gene transcription. Indeed, PRKD3 silenc-
ing led to a reduction in the expression of both cFOS and cJUN at both the mRNA and protein
levels, as previously shown to be critical for MMP1 and MMP13 expression [19]; the induction of
FOS has already been attributed to STAT3 activation [19]. Moreover, phosphorylation of cJun by
JNK (Ser63/93) as well as by PKD isotypes (Ser58) has been reported [42], thus generating the tran-
scriptionally active AP-1 (cFos/cJun) complexes associated with MMP1/13 transcription [16].
The bone abnormalities in a gene-trap prkd3 deletion mouse [34] also support a key role for
PKD3 in the regulation of MMP1/13 expression in chondrocytes and cartilage.
Of the other collagenolytic MMPs, MMP14 does not possess a promoter-proximal AP-1 ele-
ment [43,44] and was unaffected following PRKD3 silencing as we would predict. Bioinformat-
ics has identified a potential proximal AP-1 for MMP8 [44] and, in line with our findings of
reduced AP-1 expression, this MMP was also supressed. However, although many non-canon-
ical AP-1 sequences have been shown to be functional, other reports do not support the pres-
ence of a proximal AP-1 element for MMP8 [43,45] which would indicate other regulatory
mechanisms being impacted by PKD3 activity following cytokine stimulation.
We provide further evidence for a critical role for cFos in the cytokine-mediated upregula-
tion of MMP1 and MMP13 since the effect of PRKD3 silencing on FOS expression was specific.
Importantly, silencing of either PRKD1 or PRKD2 had no modulatory effects on MMP1/13,
FOS or JUN (S4 and S6 Figs).
Despite a demonstrable role for the immediate early gene FOS and AP-1(cFos/cJun)-depen-
dent induction of MMP1 and MMP13 (reviewed in [46]), we have also reported an absence of
cFos binding to the MMP13 promoter indicative of an indirect role for such cFos/cJun com-
plexes [13]. Indeed, cytokine-induced MMP13 expression involved the bZIP transcriptional reg-
ulator ATF3, the expression of which was AP-1(cFos/cJun)-dependent [13]. The obvious
corollary therefore was that ATF3 expression would be supressed following PRKD3 silencing
thus reducing its ability to transcriptionally regulate MMP13. Our findings herein confirm this
mechanism and further highlight that although AP-1 (cFos/cJun) complexes are critical for
cytokine-induced expression of genes such as MMP13, their role is indeed indirect: this is also
most likely the case for MMP1 [13] although no such regulatory factors have yet been reported.
Furthermore, earlier findings indicate that the magnitude of FOS expression following pro-
inflammatory stimulation appears to directly influence the subsequent levels of MMP expres-
sion [17] which requires the expression of AP-1-dependent transcriptional regulators [13]. This
is probably the case for other examples of complex pro-inflammatory stimuli that markedly
Fig 5. Effect of PRKD3 gene silencing on the expression of AP-1 factors in human chondrocytes. Following
transfection with siRNA specific to PRKD3 (black bars) or non-targeting siCon (white bars) (both 100 nM), primary
human articular chondrocytes were stimulated with IL-1+OSM as detailed in the Methods for 1 h unless stated
otherwise. (A) Cell lysates were subjected to real-time RT-PCR (n = 6; mean ± S.E.) for FOS (upper panel) or JUN
(lower panel) as described in Methods. Data are presented as relative expression levels normalised to 18S rRNA
housekeeping gene, where , p0.01 versus siCon. (B and C) Nuclear fractions were prepared and subjected to
SDS-PAGE and immunoblotting using the antibodies indicated. Scans from multiple blots were combined and the
relative density values presented for the individual antibodies used (C), where , p0.01 vs the relevant siCon time
point. All data are representative of at least three separate chondrocyte populations.
https://doi.org/10.1371/journal.pone.0195864.g005
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enhance MMP expression (eg. [5,6,8,14,17,18]. For cytokine-induced MMP13 we further con-
firm the involvement of ATF3, the expression of which is critically reliant upon phosphoryla-
tion of PKD3.
Fig 6. Effect of PRKD3 gene silencing on ATF3 expression in human chondrocytes. Following transfection with
siRNA specific to PRKD3 (black bars) or non-targeting siCon (white bars) (both 100 nM), primary human articular
chondrocytes were stimulated with IL-1+OSM as detailed in the Methods for 75 min unless stated otherwise. (A) Cell
lysates were subjected to real-time RT-PCR (n = 6; mean ± S.E.) for ATF3 as described in Methods. Data are presented
as relative expression levels normalised to 18S rRNA housekeeping gene, where , p0.001 versus siCon. (B) Nuclear
fractions were prepared and subjected to SDS-PAGE and immunoblotting using the antibodies indicated. Scans from
multiple blots were combined and the relative density values presented (C), where , p0.01 vs siCon. All data are
representative of at least two separate chondrocyte populations.
https://doi.org/10.1371/journal.pone.0195864.g006
Fig 7. Proposed mechanism for the involvement of PKD3 in cytokine-stimulated MMP13 induction in human
chondrocytes. Stimulation by IL-1 and OSM mediates the phosphorylation and activation of PKCι, whilst OSM
stimulation leads to activation of the JAK/STAT pathway including Tyr705 phosphorylation of STAT3. PKCι
phosphorylates/activates ERK as well as PKD3 at Ser731/735, leading to PKD3 Ser916 autophosphorylation. In turn, this
leads to the phosphorylation of JNK which induces Ser phosphorylation of STAT3, priming it for transcription, as well
as stabilising and phosphorylating cJun (PKD3 may also directly phosphorylate cJun). Both STAT3 and ERK (via Elk1
activation) lead to the induction of FOS, and when combined with phospho-cJUN drives the expression of various
transcriptional regulators which regulate the resulting MMP induction including ATF3-dependent MMP13
expression. The scheme is based on the current study and input from Refs. (13,17–19,22,39–46).
https://doi.org/10.1371/journal.pone.0195864.g007
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Conclusion
Our data indicate that PKD3 functions downstream of PKCι to affect the cytokine-mediated
induction of MMP1 and MMP13 in human chondrocytes. Thus, PKD3 may represent a novel
therapeutic target for consideration in the better management of inflammatory joint diseases,
as well as other pathologies associated with aberrant collagenase expression and ECM
catabolism.
Supporting information
S1 Fig. Confirmation of antibody specificity using human chondrocyte lysates. The speci-
ficity of each antibody used in the study was confirmed using whole cell lysates, except for
MEK2 and lamin A/C (cytoplasmic and nuclear extracts, respectively), prepared as described
in the Methods from primary human articular chondrocytes either unstimulated or stimulated
with IL-1 (0.2 ng/ml) ± OSM (10 ng/ml). Following SDS-PAGE, proteins were transferred to
PVDF membranes and probed with the indicated antibodies. Full-length blots are presented
to highlight the specific immuno-reactivity of each antibody (the arrow indicates the expected
molecular mass).
(PDF)
S2 Fig. Effect of PKD inhibition on collagenase expression in human chondrocytes. Pri-
mary human articular chondrocytes were stimulated with IL-1 (0.2 ng/ml) alone, OSM (10 ng/ml)
alone or IL-1+OSM as detailed in the Methods for 20 min. Cells were pre-treated with Gӧ6983
(20 μM; PKCi) or a DMSO vehicle control for 1 h prior to stimulation, and then lysed and immu-
noblotted with the indicated antibodies.
(PDF)
S3 Fig. Confirmation of kinase isoform knockdown following gene silencing in primary
human chondrocytes. Specificity of shRNA and siRNAs was assessed in primary human artic-
ular chondrocytes using immunoblotting (using the antibodies indicated), whilst fluorescent
microscopy was also used to assess lentiviral transduction. Following transfection with siRNA
specific to PRKCI, PRKCZ, PRKD2, PRKD3, JNK1, JNK2 or non-targeting siCon (100 nM)
(A-C) or lentiviral shRNA (MOI = 30) specific to PRKD1 or shCon (B), as described in the
Methods, cells were lysed and immunoblotted with the indicated antibodies. Fluorescent
microscopy was used to assess lentiviral transduction (B). All data are representative of at least
three separate chondrocyte populations.
(PDF)
S4 Fig. Gene silencing of PRKD1 or PRKD2 does not supress cytokine-induced MMP1/13
expression. Following transduction with lentiviral shRNA (MOI = 30) specific to PRKD1 or
shCon (A), or transfection with siRNA specific for PRKD2 or a non-targeting siCon (100 nM)
(B), primary human articular chondrocytes were stimulated with IL-1+OSM as described in
the Methods for 24 h. Cell lysates were then subjected to real-time PCR (n = 6; mean ± S.E.)
for MMP1 or MMP13 (upper and lower panels, respectively) as described in Methods. Data
are presented as relative expression levels normalised to 18S rRNA housekeeping gene, where
, p0.001, , p0.01 versus the relevant Control (ns = not significant). All data are repre-
sentative of at least three separate chondrocyte populations.
(PDF)
S5 Fig. Gene silencing of PRKD3 selectively supresses cytokine-induced MMP expression.
Following transfection with siRNA specific for PRKD3 or a non-targeting siCon (100 nM),
primary human articular chondrocytes were stimulated with IL-1+OSM as described in the
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Methods for 24 h. Cell lysates were then subjected to real-time PCR (n = 6; mean ± S.E.) for
MMP8 and MMP14 (upper and lower panels, respectively) as described in Methods. Data are
presented as relative expression levels normalised to 18S rRNA housekeeping gene, where ,
p0.01, versus siCon (ns = not significant). All data are representative of at least three separate
chondrocyte populations.
(PDF)
S6 Fig. Gene silencing of PRKD1 or PRKD2 does not supress cytokine-induced FOS and
JUN expression. Following transduction with lentiviral shRNA (MOI = 30) specific to PRKD1
or shCon (A), or transfection with siRNA specific for PRKD2 or a non-targeting siCon (100
nM) (B), primary human articular chondrocytes were stimulated with IL-1+OSM as described
in the Methods for 1 h. Cell lysates were then subjected to real-time PCR (n = 6; mean ± S.E.)
for FOS or JUN (upper and lower panels, respectively) as described in Methods. Data are pre-
sented as relative expression levels normalised to 18S rRNA housekeeping gene, where
ns = not significant versus the relevant Control. All data are representative of at least three sep-
arate chondrocyte populations.
(PDF)
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